{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:59:46Z","timestamp":1761893986520},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1996,6,1]],"date-time":"1996-06-01T00:00:00Z","timestamp":833587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1996,6]]},"DOI":"10.1007\/bf00120497","type":"journal-article","created":{"date-parts":[[2004,9,17]],"date-time":"2004-09-17T16:40:24Z","timestamp":1095439224000},"page":"275-282","source":"Crossref","is-referenced-by-count":41,"title":["Sympathetic nervous system in salt-sensitive and obese hypertension: Amelioration of multiple abnormalities by a central sympatholytic agent"],"prefix":"10.1007","volume":"10","author":[{"given":"Paul","family":"Ernsberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Koletsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bedol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00120497_CR1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-8703(89)90592-9","volume":"118","author":"SE Kjeldsen","year":"1989","unstructured":"Kjeldsen SE, Schork NJ, Leren P, Eide IK. Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension. Am Heart J 1989;118:775\u2013781.","journal-title":"Am Heart J"},{"key":"BF00120497_CR2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004872-199101000-00012","volume":"9","author":"S Julius","year":"1991","unstructured":"Julius S, Krause L, Schork NJ, et al. Hyperkinetic borderline hypertension of Tecumseh, Michigan. J Hypertens 1991;9:77\u201384.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"BF00120497_CR3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199423001-00002","volume":"23","author":"L Landsberg","year":"1994","unstructured":"Landsberg L. Pathophysiology of obesity-related hypertension: Role of insulin and the sympathetic nervous system. J Cardiovasc Pharmacol 1994;23(Suppl 1):S1-S8.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF00120497_CR4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/jn\/121.8.1146","volume":"121","author":"GA Bray","year":"1991","unstructured":"Bray GA. Obesity, a disorder of nutrient partitioning: The MONA LISA hypothesis. J Nutr 1991;121:1146\u20131162.","journal-title":"J Nutr"},{"key":"BF00120497_CR5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.HYP.24.6.699","volume":"24","author":"P Ernsberger","year":"1994","unstructured":"Ernsberger P, Koletsky RJ, Baskin JS, Foley M. Refeeding hypertension in obese spontaneously hypertensive rats. Hypertension 1994;24:699\u2013705.","journal-title":"Hypertension"},{"key":"BF00120497_CR6","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1111\/j.1440-1681.1995.tb02905.x","volume":"22","author":"RJ Koletsky","year":"1995","unstructured":"Koletsky RJ, Boccia J, Ernsberger P. Acceleration of renal disease in obese SHR by exacerbation of hypertension. Clin Exp Pharmacol Physiol 1995;22:S254-S256.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF00120497_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/10641969509087078","volume":"17","author":"S Julius","year":"1995","unstructured":"Julius S. The defense reaction: A common denominator of coronary risk and blood pressure in neurogenic hypertension. Clin Exp Hypertens 1995;17:375\u2013386.","journal-title":"Clin Exp Hypertens"},{"issue":"Suppl I","key":"BF00120497_CR8","doi-asserted-by":"crossref","first-page":"I28","DOI":"10.1161\/01.HYP.19.1_Suppl.I28","volume":"19","author":"GF DiBona","year":"1992","unstructured":"DiBona GF. Sympathetic neural control of the kidney in hypertension. Hypertension 1992;19(Suppl I):I28-I35.","journal-title":"Hypertension"},{"key":"BF00120497_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF01578751","volume":"76","author":"F Ceci","year":"1989","unstructured":"Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm 1989;76:109\u2013117.","journal-title":"J Neural Transm"},{"key":"BF00120497_CR10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/diacare.14.3.240","volume":"14","author":"PA Daly","year":"1991","unstructured":"Daly PA, Landsberg L. Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system. Diabet Care 1991;14:240\u2013248.","journal-title":"Diabet Care"},{"key":"BF00120497_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2796.1994.tb01031.x","volume":"235","author":"I Zavaroni","year":"1994","unstructured":"Zavaroni I, Bonini L, Fantuzzi M, Dall'aglio E, Passeri M, Reaven GM. Hyperinsulinaemia, obesity, and syndrome X. J Intern Med 1994;235:51\u201356.","journal-title":"J Intern Med"},{"key":"BF00120497_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.me.44.020193.001005","volume":"44","author":"GM Reaven","year":"1993","unstructured":"Reaven GM. Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu Rev Med 1993;44:121\u2013131.","journal-title":"Annu Rev Med"},{"key":"BF00120497_CR13","first-page":"A187","volume":"9","author":"RJ Koletsky","year":"1995","unstructured":"Koletsky RJ, Collins LA, Bedol D, Ernsberger P. Obese SHR as a model of human syndrome X. FASEB J 1995;9:A187.","journal-title":"FASEB J"},{"key":"BF00120497_CR14","first-page":"373","volume-title":"Genetic Hypertension","author":"RJ Koletsky","year":"1992","unstructured":"Koletsky RJ, Ernsberger P. Obese SHR (Koletsky Rat): A model for the interactions between obesity and hypertension. In: Sassard J, ed. Genetic Hypertension. London: John Libbey, 1992:373\u2013375."},{"key":"BF00120497_CR15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.21.6.1039","volume":"21","author":"P Ernsberger","year":"1993","unstructured":"Ernsberger P, Koletsky RJ, Collins LA, Douglas JG. Renal angiotensin receptor mapping in obese spontaneously hypertensive rats. Hypertension 1993;21:1039\u20131045.","journal-title":"Hypertension"},{"key":"BF00120497_CR16","first-page":"129","volume":"80","author":"S Koletsky","year":"1975","unstructured":"Koletsky S. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 1975;80:129\u2013142.","journal-title":"Am J Pathol"},{"key":"BF00120497_CR17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.HYP.24.6.699","volume":"24","author":"P Ernsberger","year":"1994","unstructured":"Ernsberger P, Koletsky RJ, Collins LA. Lethal consequences of a high salt diet in obese SHR. Hypertension 1994;24:376.","journal-title":"Hypertension"},{"key":"BF00120497_CR18","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1111\/j.1440-1681.1995.tb02905.x","volume":"22","author":"RJ Koletsky","year":"1995","unstructured":"Koletsky RJ, Boccia J, Ernsberger P. Acceleration of renal disease in obese SHR by exacerbation of hypertension. Clin Exp Pharmacol Physiol 1995;22:S254-S256.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF00120497_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.HYP.22.3.285","volume":"22","author":"Y Nakamura","year":"1993","unstructured":"Nakamura Y, Calhoun DA, Chen Y-F, Wyss JM, Oparil S. Excitatory sympathetic reflex in NaCl-sensitive spontaneously hypertensive rats. Hypertension 1993;22:285\u2013291.","journal-title":"Hypertension"},{"key":"BF00120497_CR20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1440-1681.1988.tb01014.x","volume":"15","author":"R Nicolantonio Di","year":"1988","unstructured":"Di Nicolantonio R, Silvapulle MJ. Blood pressure, salt appetite and mortality of genetically hypertensive and normotensive rats maintained on high and low salt diets from weaning. Clin Exp Pharmacol Physiol 1988;15:741\u2013751.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BF00120497_CR21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1995.tb32388.x","volume":"763","author":"P Ernsberger","year":"1995","unstructured":"Ernsberger P, Graves ME, Graff LM, et al. I1-Imidazoline receptors: Definition, characterization, distribution and transmembrane signaling. Ann NY Acad Sci 1995;763:22\u201342.","journal-title":"Ann NY Acad Sci"},{"key":"BF00120497_CR22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","volume":"83","author":"GL Peterson","year":"1977","unstructured":"Peterson GL. A simplification of the protein assay method of Lowry et al, which is more generally applicable. Anal Biochem 1977;83:346\u2013356.","journal-title":"Anal Biochem"},{"key":"BF00120497_CR23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0272-6386(12)70174-9","volume":"22","author":"JR Neuringer","year":"1993","unstructured":"Neuringer JR, Brenner BM. Hemodynamic theory of progressive renal disease: A 10-year update in brief review. Am J Kidney Dis 1993;22:98\u2013104.","journal-title":"Am J Kidney Dis"},{"key":"BF00120497_CR24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ajh\/5.7.437","volume":"5","author":"T Irzyniec","year":"1992","unstructured":"Irzyniec T, Mall G, Greber D, Ritz E. Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats: A micromophometric study. Am J Hypertens 1992;5:437\u2013443.","journal-title":"Am J Hypertens"},{"key":"BF00120497_CR25","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/clinchem\/38.9.1802","volume":"38","author":"P Metcalf","year":"1992","unstructured":"Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: Effect of obesity, hypertension, and hyperlipidemia. Clin Chem 1992;38:1802\u20131808.","journal-title":"Clin Chem"},{"key":"BF00120497_CR26","first-page":"S35","volume":"39","author":"JF Moorhead","year":"1991","unstructured":"Moorhead JF. Lipids and progressive kidney disease. Kidney Int 1991;39:S35-S40.","journal-title":"Kidney Int"},{"key":"BF00120497_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000168588","volume":"13","author":"VS Kamanna","year":"1993","unstructured":"Kamanna VS, Kirschenbaum MA. Association between very-low-density lipoprotein and glomerular injury in obese Zucker rats. Am J Nephrol 1993;13:53\u201358.","journal-title":"Am J Nephrol"},{"key":"BF00120497_CR28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0272-6386(12)70172-5","volume":"22","author":"MP O'Donnell","year":"1993","unstructured":"O'Donnell MP, Kasiske BL, Kim Y, Schmitz PG, Keane WF. Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am J Kidney Dis 1993;22:83\u201389.","journal-title":"Am J Kidney Dis"},{"key":"BF00120497_CR29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3181\/00379727-151-39212","volume":"151","author":"S Koletsky","year":"1976","unstructured":"Koletsky S, Puterman DI. Effect of low calorie diet on the hyperlipidemia, hypertension, and life span of genetically obese rats. Proc Soc Exp Biol Med 1976;151:368\u2013371.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF00120497_CR30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ajcn\/60.5.647","volume":"60","author":"DJ Goldstein","year":"1994","unstructured":"Goldstein DJ, Potvin JH. Long-term weight loss: The effect of pharmacologic agents. Am J Clin Nutr 1994;60:647\u2013657.","journal-title":"Am J Clin Nutr"},{"key":"BF00120497_CR31","first-page":"199","volume":"18","author":"JM Bremer","year":"1994","unstructured":"Bremer JM, Scott RS, Lintott CJ. Defenfluramine reduces cardiovascular risk factors. Int J Obes 1994;18:199\u2013205.","journal-title":"Int J Obes"},{"key":"BF00120497_CR32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0091-3057(93)90269-Y","volume":"45","author":"JS Fisler","year":"1993","unstructured":"Fisler JS, Underberger SJ, York DA, Bray GA. d-Fenfluramine in a rat model of dietary fat-induced obesity. Pharmacol Biochem Behav 1993;45:487\u2013493.","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl 1","key":"BF00120497_CR33","first-page":"19","volume":"5","author":"EC Kaan","year":"1995","unstructured":"Kaan EC, Br\u00fcckner R, Frohly P, Tulp M, Sch\u00e4fer SG, Ziegler D. Effects of agmatine and moxonidine on glucose metabolism: An integrated approach towards pathophysiological mechanisms in cardiovascular metabolic disorders. Cardiovasc Risk Factors 1995;5(Suppl 1):19\u201327.","journal-title":"Cardiovasc Risk Factors"},{"key":"BF00120497_CR34","first-page":"165","volume":"21","author":"RA Fronzo De","year":"1981","unstructured":"De Fronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 1981;21:165\u2013171.","journal-title":"Diabetologia"},{"key":"BF00120497_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ajh\/2.3.171","volume":"2","author":"JE Hall","year":"1989","unstructured":"Hall JE, Coleman TG, Mizelle HL. Does chronic hyperinsulinemia cause hypertension? Am J Hypertens 1989;2:171\u2013173.","journal-title":"Am J Hypertens"},{"key":"BF00120497_CR36","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJM199005243222101","volume":"322","author":"C Bouchard","year":"1990","unstructured":"Bouchard C, Tremblay A, Despr\u00e9s J-P, et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990;322:1477\u20131482.","journal-title":"N Engl J Med"},{"key":"BF00120497_CR37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.HYP.17.5.669","volume":"17","author":"RJ Trois","year":"1991","unstructured":"Trois RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669\u2013677.","journal-title":"Hypertension"},{"key":"BF00120497_CR38","first-page":"172","volume":"264","author":"P Ernsberger","year":"1993","unstructured":"Ernsberger P, Damon TH, Graff LM, Christen MO, Sch\u00e4fer SG. Moxonidine, a centrally-acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. J Pharmacol Exp Ther 1993;264:172\u2013182.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF00120497_CR39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1527-3466.1993.tb00198.x","volume":"11","author":"P Ernsberger","year":"1993","unstructured":"Ernsberger P, Elliott HL, Weimann H-J, et al. Moxonidine: A second-generation central antihypertensive agent. Cardiovasc Drug Rev 1993;11:411\u2013431.","journal-title":"Cardiovasc Drug Rev"},{"issue":"Suppl 1","key":"BF00120497_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00877082","volume":"8","author":"P Ernsberger","year":"1994","unstructured":"Ernsberger P, Haxhiu MA, Graff LM, et al. A novel mechanism of action for hypertension control: Moxonidine as a selective I1-imidazoline agonist. Cardiovasc Drugs Ther 1994;8(Suppl 1):27\u201341.","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF00120497_CR41","first-page":"168","volume":"228","author":"NW Tullio Di","year":"1984","unstructured":"Di Tullio NW, Cieslinki L, Matthews WD, Storer B. Mechanisms involved in the hyperglycemic response induced by clonidine and other 282\u20131 agonists. J Pharmacol Exp Ther 1984;228:168\u2013173.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF00120497_CR42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0006-8993(92)91001-U","volume":"587","author":"S Tsujii","year":"1992","unstructured":"Tsujii S, Bray GA. Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists. Brain Res 1992;587:226\u2013232.","journal-title":"Brain Res"},{"key":"BF00120497_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-8993(84)91013-8","volume":"309","author":"JT McCabe","year":"1984","unstructured":"McCabe JT, De Bellis M, Leibowitz SF. Clonidine-induced feeding: Analysis of central sites of action and fiber projections mediating this response. Brain Res 1984;309:85\u2013104.","journal-title":"Brain Res"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00120497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00120497\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00120497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:02:49Z","timestamp":1585890169000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00120497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6]]},"references-count":43,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1996,6]]}},"alternative-id":["BF00120497"],"URL":"https:\/\/doi.org\/10.1007\/bf00120497","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,6]]}}}